---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-016977"
form_type: "8-K"
ticker: "ANGO"
cik: "0001275187"
company_name: "ANGIODYNAMICS INC"
filed_at: "2024-04-01T23:59:59+00:00"
generated_at: "2026-06-04T04:23:09.268941+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# AngioDynamics settles patent litigation with BD; $7M upfront, $2.5M annual minimums

## Summary
- One-time payment of $7M to BD, with $3M due within 5 business days and remainder over 12 months.
- Minimum annual payments of $2.5M for six years through Feb 2029; additional payments based on 6% of port product net sales.
- Contingent $3M payment due if Federal Circuit reverses invalidity findings in pending appeal (CAFC No. 23-2056).
- Cross-licenses granted: BD licenses certain port patents to AngioDynamics; AngioDynamics licenses certain catheter patents.
- Mutual covenants not to sue and releases; no admission of misconduct or liability.

## SEC filing metadata
- accession: 0001140361-24-016977
- form_type: 8-K
- ticker: ANGO
- cik: 0001275187
- company_name: ANGIODYNAMICS INC
- filed_at: 2024-04-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1275187/000114036124016977/0001140361-24-016977-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1275187/000114036124016977/ef20025660_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-016977
- JSON: https://secwatch.observer/filing/0001140361-24-016977.json
- Plain text: https://secwatch.observer/filing/0001140361-24-016977.txt

## Key facts
- Material Agreements
  ANGIODYNAMICS INC entered into Settlement Agreement with Becton, Dickinson and Company, C.R. Bard, Inc. and Bard Peripheral Vascular Inc. valued at one-time lump sum payment to BD in the amount of $7 million, $3 million of which will be payable wit (effective 2024-03-31).
  - Action: entry
  - Agreement: settlement
  - Counterparty: Becton, Dickinson and Company, C.R. Bard, Inc. and Bard Peripheral Vascular Inc.
  - Value: one-time lump sum payment to BD in the amount of $7 million, $3 million of which will be payable wit
  - Effective: 2024-03-31
  source text: On March 31, 2024, AngioDynamics and BD entered into a Settlement Agreement (the “Settlement Agreement”) to resolve the Actions.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1275187/000114036124016977/0001140361-24-016977-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.